Risk management
This article was originally published in The Gray Sheet
Executive Summary
Final FDA guidance entitled "Medical Device Use - Safety: Incorporating Human Factors Engineering Into Risk Management" is issued July 18. Validation of a device with realistic users is always necessary at the design process, guidance states, but may not need to be extensive "if small scale iterative testing of interface components is done adequately as the device was developed"
You may also be interested in...
AAMI/ANSI Human Factors Revised Guideline Will Soon Be Ready For Use
The Association for the Advancement of Medical Instrumentation and the American National Standards Institute expect to publish revised guidelines on human factors design processes for medical devices by the summer of 2001.
US Q1 Consumer Health Earnings Preview: Label This One Historic And Challenging But Promising
US OTC drug and supplement firms’ reports of results for the first three months of 2024 began on April 19 with P&G. JP Morgan analysts say while “some retailers in the US in particular” are reducing consumer health inventories, for the overall sector they expect “a healthier balance of positive volume and lower pricing contribution.”